Bococizumab is a humanized monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a regulator of LDL receptor degradation. By reducing circulating LDL cholesterol, Bococizumab is used in preclinical studies of hypercholesterolemia and cardiovascular risk reduction.
Bococizumab is a humanized monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a regulator of LDL receptor degradation. By reducing circulating LDL cholesterol, Bococizumab is used in preclinical studies of hypercholesterolemia and cardiovascular risk reduction.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: